Ananya Choudhury

Research interests

Publications

• Current best practice for bladder cancer: a narrative review of diagnostics and treatments

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)01188-6

• Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials

  The Lancet Oncology · 2021 · https://doi.org/10.1016/s1470-2045(20)30607-0

• Sarcopenia in cancer: Risking more than muscle loss

  Technical Innovations & Patient Support in Radiation Oncology · 2020 · https://doi.org/10.1016/j.tipsro.2020.10.001

• The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy

  Frontiers in Oncology · 2020 · https://doi.org/10.3389/fonc.2020.01328

• Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19

  Advances in Radiation Oncology · 2020 · https://doi.org/10.1016/j.adro.2020.03.010

• What Is the Significance of Variant Histology in Urothelial Carcinoma?

  European Urology Focus · 2019 · https://doi.org/10.1016/j.euf.2019.09.003

• EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

  Annals of Oncology · 2019 · https://doi.org/10.1093/annonc/mdz296

• The transformation of radiation oncology using real-time magnetic resonance guidance: A review

  European Journal of Cancer · 2019 · https://doi.org/10.1016/j.ejca.2019.07.021

• EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

  European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.09.035

• Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

  Annals of Oncology · 2018 · https://doi.org/10.1093/annonc/mdy072

• Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer

  EBioMedicine · 2018 · https://doi.org/10.1016/j.ebiom.2018.04.019

• Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A “Game Changer” for Prostate Treatment?

  International Journal of Radiation Oncology*Biology*Physics · 2017 · https://doi.org/10.1016/j.ijrobp.2017.10.020

• Phase II Study of Conformal Hypofractionated Radiotherapy With Concurrent Gemcitabine in Muscle-Invasive Bladder Cancer

  Journal of Clinical Oncology · 2011 · https://doi.org/10.1200/jco.2010.31.5721

• European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene

  Human Molecular Genetics · 2011 · https://doi.org/10.1093/hmg/ddr303

• A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer

  Nature Genetics · 2010 · https://doi.org/10.1038/ng.558

• MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

  Cancer Research · 2010 · https://doi.org/10.1158/0008-5472.can-10-1202

• Similar Treatment Outcomes for Radical Cystectomy and Radical Radiotherapy in Invasive Bladder Cancer Treated at a United Kingdom Specialist Treatment Center

  International Journal of Radiation Oncology*Biology*Physics · 2007 · https://doi.org/10.1016/j.ijrobp.2007.06.030

Current projects

No projects listed.